Study Suggests Weight Loss Drug Semaglutide May Slow Biological Aging
A recent study has found that semaglutide, a GLP-1 drug commonly used for weight loss, may also slow biological aging. Conducted on 108 adults with HIV-associated lipohypertrophy, the study used epigenetic clocks to measure biological aging. Participants receiving semaglutide injections showed a 9% slower aging rate compared to those on a placebo. The drug appeared to counteract accelerated aging effects linked to chronic inflammation and immune system activation, common in people with HIV. These findings suggest that semaglutide could have broader implications beyond weight management, potentially benefiting the general population. 
